Details for 2018769793

Up to date per 05.04.2026

Actions

Title / Product Name

1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA ENTHALTENDE PHARMAZEUTISCHE WÄSSRIGE FORMULIERUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018769793

EP Publication Number

3672571

E-Number

1435613

Language

PCT Number

IB18056281

Publication Date

01.07.2020 A

06.10.2021 B1

Registration Date

06.10.2021

AT Publication Date

15.10.2021

Application Date

20.08.2018

Registration Number

Priorities

25.08.2017

201762550007 P

07.06.2018

201862681720 P

25.07.2018

201862703022 P

IPC

A61K 9/00 20060101AFI20190301BHEP

Maximum Duration of Protection

20.08.2038

Owner

Pfizer Inc.235 East 42nd Street New York, NY 10017US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

HUSSEY, James Josephc/o Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJGB

BRIGHT, Andrew Gilbertc/o Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJGB

Information about Fees